Telomeres, they are called
Owen D, Little S, Leach R, Wyncoll D
However, Rybelsus may lead to greater weight loss (8-11% body weight reduction) compared to Trulicity (3-5%), while Trulicity has specific FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease or multiple cardiovascular risk factors
In certain cases, patients may present with nonspecific symptoms like fatigue, unexplained weight loss, or discomfort in the upper right abdomen, particularly in those with more advanced disease or NASH
Semaglutide, originally developed as a treatment for type 2 diabetes, has garnered significant attention for its remarkable impact on weight loss in addition to its primary role in managing blood sugar levels